3FQ9: Design Of An Insulin Analog With Enhanced Receptor-Binding Selectivity. Rationale, Structure, And Therapeutic Implications
reference: Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications., Zhao M, Wan ZL, Whittaker L, Xu B, Phillips NB, Katsoyannis PG, Ismail-Beigi F, Whittaker J, Weiss MA, J Biol Chem. 2009 Nov 13;284(46):32178-87. Epub 2009 Sep 22. PMID: 19773552

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).